Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,041.3
-79.3 (-2.54%)

 

  • STI Straits Times Index
    3,041.3
    -79.3 (-2.54%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,514.0
    3.4 (0.23%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,475.3
    -377.0 (-1.58%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,563.9
    1.2 (0.03%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,821.8
    -462.2 (-1.63%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,533.9
    -74.4 (-1.13%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,947.1M
  • Value: 3,865.3M
  • Rise: 100
  • Fall: 254
  • Unch: 403

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Lippo Malls Tr0.054-
Singtel2.360-0.050
Sembcorp Marine0.085+0.002
Genting Sing0.770-0.020
Medtecs Intl0.440-0.060
HGH0.020+0.001
ComfortDelGro1.370-0.060
CapLand IntCom T2.110-0.030
Ascendas Reit2.920-0.070
ThaiBev0.670-0.015

World Indices

World Indices
Name Last Change
Nasdaq 15,782.8 +291.2
HSI 23,475.3 -377.0
HSCEI 8,368.5 -129.8
Jakarta 6,533.9 -74.4
Nikkei 225 27,821.8 -462.2
SSE Comp 3,563.9 +1.2
Shanghai A 3,735.2 +1.3
Shanghai B 279.4 -1.1
KOSPI 2,839.0 -70.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Annica ANNICA HOLDINGS LIMITED
Quotes 10 Minutes Delayed. Updated at 30 Nov 2021 17:06
Last (SGD): 0.001 Change: - High: - Remarks: -
Change (%): - Low: -

Company Background

The Company was incorporated in Singapore on 20 August 1983 and admitted to the Catalist Board of the SGX-ST in 2001, it is an investment holding company with subsidiaries operating mainly in Singapore, Malaysia, Indonesia and Brunei, trading in oilfield equipment & related products, designing of industrial plant & rendering of engineering services, an integrated solutions provider for renewable sector and investment holding.

Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.00007 Trailing EPS (SGD) b -0.00008 NAV (SGD) c 0.0001
PE a - Trailing PE d - Price / NAV c 10.0000
Dividend Yield (%) e - Cash In Hand (SGD) f - Issued & Paid-up Shares g 16,674,767,000
Piotroski F Score 5 Market Cap (M) 16.675 Free Float (%) -
Return on Equity (ROE) (%) h n.m. Revenue Growth (%) TTM i -8.507
Net Earnings Growth (%) j -89.084 Net Debt/Equity k Net Cash
Under CPF Investment Scheme (CPFIS) Yes
Sector & Industry Manufacturing - Medical Specialties
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 11 Nov 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

Not enough data to show total shareholder returns
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Annica SGX 16.675 - - 10.0000 -
Industry Medical Specialties SGX 1,374.606 2.923 2.960 3.3907 18.906
Index FTSE ST Catalist Index SGX 61.235 26.636 20.879 1.3970 1.977
Local Peer Top Glove SGX 7,646.784 3.004 3.004 3.9204 19.868
Local Peer Medtecs Intl SGX 240.421 1.381 1.651 0.9578 15.335
Local Peer UGHealthcare SGX 246.504 2.076 2.076 1.2932 1.277
Local Peer Biolidics SGX 50.701 - - 9.5980 -
Local Peer Yunnan Energy SGX 46.549 - - 1.4359 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 255,646.521 40.101 29.848 6.6041 0.137
Global Peer DANAHER CORP NYSE 233,323.682 66.474 40.777 5.8065 0.219
Global Peer ABBOTT LABORATORIES NYSE 226,394.169 50.614 31.391 6.5770 1.197
Global Peer MEDTRONIC PLC NYSE 148,311.161 41.129 38.195 2.8806 2.105
Global Peer INTUITIVE SURGICAL INC NASDAQ 119,492.807 112.665 70.739 10.4718 -
Global Peer STRYKER CORP NYSE 91,857.940 57.447 48.346 6.4789 0.964
Global Peer BECTON DICKINSON & CO NYSE 69,191.087 34.561 34.561 2.9223 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 69,120.017 83.944 46.788 12.4737 -
Global Peer DEXCOM INC NASDAQ 55,343.431 112.122 104.560 25.9086 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 54,990.364 - 52.774 3.3404 -
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), PERKINELMER INC (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), WATERS CORP (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), COOPER COS INC (NYSE), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), DENTSPLY SIRONA INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), NOVOCURE LTD (NASDAQ), PENUMBRA INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), MICROPORT SCIENTIFIC CORPORATION (HKEx), ANGELALIGN TECHNOLOGY INC (HKEx), SHANGHAI MICROPORT MEDBOT (GROUP) C (HKEx), GLOBUS MED INC (NYSE), STEVANATO GROUP S.P.A. (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), SHANDONG WEIGAO GROUP MEDICAL (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), QUIDEL CORP (NASDAQ), INMODE LTD (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), SOTERA HEALTH CO (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), TOPGLOV (Bursa), ICU MEDICAL INC (NASDAQ), HARTA (Bursa), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), STAAR SURGICAL CO (NASDAQ), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), INARI MEDICAL INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), NEVRO CORP (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), HAEMONETICS CORP (NYSE), CYTEK BIOSCIENCES INC (NASDAQ), NUVASIVE INC (NASDAQ), AXONICS INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), VENUS MEDTECH (HANGZHOU) INC (HKEx), CAREDX INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), GLAUKOS CORPORATION (NYSE), LANTHEUS HOLDINGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), CUE HEALTH INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), VICARIOUS SURGICAL INC (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), AVANOS MEDICAL INC (NYSE), PARAGON 28 INC (NYSE), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), SILK ROAD MEDICAL INC (NASDAQ), PEIJIA MEDICAL LIMITED (HKEx), KANGJI MEDICAL HLDGS LTD (HKEx), ATRION CORP (NASDAQ), BUTTERFLY NETWORK INC (NYSE), SUPERMX (Bursa), CERUS CORP (NASDAQ), PULMONX CORPORATION (NASDAQ), NANOSONICS LIMITED (ASX), VAREX IMAGING CORPORATION (NASDAQ), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), ORTHOPEDIATRICS CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), BIOVENTUS INC (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), VIEWRAY INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), TREACE MED CONCEPTS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), NATUS MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), INTERCURE LTD (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), SISRAM MEDICAL LTD (HKEx), INOGEN INC (NASDAQ), CRYOLIFE INC (NYSE), ORASURE TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), AIRSCULPT TECHNOLOGIES INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), 908 DEVICES INC (NASDAQ), SI BONE INC (NASDAQ), SURMODICS INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), DERMTECH INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), VAPOTHERM INC (NYSE), IRADIMED CORP (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), NYXOAH SA (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), APYX MEDICAL CORPORATION (NASDAQ), ACCURAY INCORPORATED (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), SOLITON INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), METRICS INCOME OPPORTUNITIES TRUST (ASX), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), UTAH MEDICAL PRODUCTS (NASDAQ), AXOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), AVITA MEDICAL INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), FLUIDIGM CORP DEL (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), PAVMED INC (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), AROA BIOSURGERY LTD (ASX), ATOSSA THERAPEUTICS INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), SONENDO INC (NYSE), DARIOHEALTH CORP (NASDAQ), NEUROPACE INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), CVRX INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), SIENTRA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), IMPEDIMED LIMITED (ASX), ONCOCYTE CORP (NASDAQ), QUOTIENT LTD (NASDAQ), EARGO INC (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), CORMEDIX INC (NASDAQ), MINERVA SURGICAL INC (NASDAQ), TELA BIO INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), CONFORMIS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), INTRICOM CORP (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CYCLOPHARM LIMITED (ASX), FONAR CORP (NASDAQ), INVACARE CORP (NYSE), NEMAURA MEDICAL INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), NEURONETICS INC (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), RGTBHD (Bursa), IRIDEX CORP (NASDAQ), ELECTROMED INC (NYSE American), BIOSIG TECHNOLOGIES INC (NASDAQ), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), SENSUS HEALTHCARE INC (NASDAQ), MICRO-X LTD (ASX), KELFRED HOLDINGS LTD (HKEx), ALPHA PRO TECH (NYSE American), SDI LTD (ASX), ACUTUS MEDICAL INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), REWALK ROBOTICS LTD (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), OPTISCAN IMAGING (ASX), TITAN MEDICAL INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), LENSAR INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), IMMUCELL CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), BIOLASE INC (NASDAQ), ENVVENO MED CORP (NASDAQ), CELSION CORPORATION (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), AVINGER INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), DIMERIX LTD (ASX), ELECTROCORE INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NUTRIBAND INC (NASDAQ), APPLIED UV INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), NEOVASC INC (NASDAQ), NEUROMETRIX INC (NASDAQ), ADVENTA (Bursa), DAXOR CORP (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), BLUEJAY DIAGNOSTICS INC (NASDAQ), COMPUMEDICS (ASX), AETHLON MEDICAL INC (NASDAQ), CARDIEX LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), YUNNAN ENERGY INTL CO LTD (HKEx), TIVIC HEALTH SYSTEMS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), RESONANCE HEALTH LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), RESHAPE LIFESCIENCES INC (NASDAQ), RESPIRI LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NASDAQ), HEARTBEAM INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), PLUS THERAPEUTICS INC (NASDAQ), CYANOTECH CORP (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), DYNATRONICS CORP (NASDAQ), LBT INNOVATIONS LTD (ASX), TRUSCREEN GROUP LTD (ASX), ADHERIUM LIMITED (ASX), LKL (Bursa), NUWELLIS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), OVENTUS MEDICAL LTD (ASX), VIVEVE MEDICAL INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), USCOM LTD (ASX), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), METALICITY LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), XTANT MEDICAL HLDGS INC (NYSE American), STAR EQUITY HOLDINGS INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.